SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-077358
Filing Date
2022-03-16
Accepted
2022-03-16 17:20:35
Documents
12
Period of Report
2022-03-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d294673d8k.htm   iXBRL 8-K 22381
  Complete submission text file 0001193125-22-077358.txt   139316

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA amrx-20220315.xsd EX-101.SCH 2854
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrx-20220315_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrx-20220315_pre.xml EX-101.PRE 10811
6 EXTRACTED XBRL INSTANCE DOCUMENT d294673d8k_htm.xml XML 3244
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38485 | Film No.: 22745819
SIC: 2834 Pharmaceutical Preparations